TITLE

MED DISCOVERY/DRAXIMAGE SIGN COLLABORATION PACT

PUB. DATE
October 2007
SOURCE
Worldwide Biotech;Oct2007, Vol. 19 Issue 10, p1
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article reports on the research collaboration agreement signed by Med Discovery and DRAXIMAGE to explore the combination of targeted protein therapeutics with radiopharmaceutical expertise. Med Discovery's proteins are potential therapeutic agents for prostate cancer. The research is for the radiolabeling of certain Med's proteins by DRAXIMAGE to assess the enhancement of their therapeutic action and their capability to detect microtumors. The proteins will be produced at Med Discovery in Switzerland and radiolabeled by DRAXIMAGE in Canada.
ACCESSION #
26715137

 

Related Articles

  • Agreements roundup.  // Diagnostics & Imaging Week;8/30/2007, Vol. 10 Issue 35, p11 

    The article reports on a research collaboration between Med Discovery and Draximage focused on combining the targeted protein therapeutics of Med Discovery with the radiopharmaceutical products of Draximage. The deal involves the radiolabeling of certain Med Discovery proteins to assess the...

  • Med Discovery, Draximage to collaborate on protein research.  // Medical Device Daily;8/23/2007, Vol. 11 Issue 161, p4 

    The article reports on the research agreement between Med Discovery and Draximage, the radiopharmaceutical division of Draxis Health, to explore the combination of the targeted protein therapeutics of Med Discovery with Draximage's radiopharmaceutical products in the therapeutics and diagnostics...

  • FROM THE LAB.  // Medical Technology & Devices Week;9/4/2007, Vol. 5 Issue 36, p1 

    The article reports on a research collaboration agreement between Med Discovery and Draximage to explore the combination of Med Discovery's targeted protein therapeutics with Draximage's radiopharmaceutical products in the therapeutic an diagnostics field. It says that Med Discovery's lead...

  • The Experts Discuss Protein Separation Techniques. Dickey, Chris // Drug Discovery & Development;Dec2003, Vol. 6 Issue 12, p51 

    Focuses on the evaluation of protein separation methods by researchers prior to mass spectrometry. Analysis of low-abundance proteins in a sample; Method of choice to minimize ionic strength of the sample; Impact of isotope labeling on gel separation.

  • DRAXIMAGE RECEIVES FDA APPROVAL FOR BRACHYSEED.  // Biotech Business;Oct2000, Vol. 13 Issue 10, p1 

    Announces that Draximage Inc. has received approval from the United States Food and Drug Administration to market its Iodine-125 BrachySeed for the treatment of prostate cancer and other localized cancers.

  • The benefits of being transient: isotope-based metabolic flux analysis at the short time scale. Nöh, Katharina; Wiechert, Wolfgang // Applied Microbiology & Biotechnology;Sep2011, Vol. 91 Issue 5, p1247 

    Metabolic fluxes are the manifestations of the co-operating actions in a complex network of genes, transcripts, proteins, and metabolites. As a final quantitative endpoint of all cellular interactions, the intracellular fluxes are of immense interest in fundamental as well as applied research....

  • Agreements.  // Cardiovascular Devices & Drugs;Jan2008, Vol. 14 Issue 1, p27 

    This section offers news briefs on agreements affecting the medical instruments and apparatus industry. Beckman Coulter reported that it is the industrial partner in a two-year research project at Thomas Jefferson University and Laboraf Diagnostica e Ricera San Raffaele SpA. BioSphere Medical...

  • Thousands of proteins affected by miRNAs. Hayden, Erica Check // Nature;7/31/2008, Vol. 454 Issue 7204, p562 

    The article focuses on the influence of microribonucleic acids (miRNAs) on proteins involved in key biological processes. The genome can control protein levels in animals by breaking down the messenger RNA (mRNA) from a gene and by stopping it from being translated into protein. Scientists used...

  • A Brief Review of Chelators for Radiolabeling Oligomers. Yuxia Liu; Guozheng Liu; Hnatowich, Donald J. // Materials (1996-1944);May2010, Vol. 3 Issue 5, p3204 

    The chemical modification of oligomers such as DNA, PNA, MORF, LNA to attach radionuclides for nuclear imaging and radiotherapy applications has become a field rich in innovation as older methods are improved and new methods are introduced. This review intends to provide a brief overview of...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics